-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Since the outbreak of the new coronary pneumonia pandemic caused by the Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Italy has been one of the earliest and most severely affected countries
Since the outbreak of the new coronary pneumonia pandemic caused by the Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Italy has been one of the earliest and most severely affected countries
This observational retrospective multicenter study collected COVID-19 data on IBD patients who received biological therapy in Italy from February 2020 to May 2020
The results of the study showed that among 1816 IBD patients, the cumulative incidence of COVID-19 was 3.
This study confirms that compared with the general population, IBD patients receiving biological therapy do not have a higher risk of COVID-19
This study confirms that compared with the general population, IBD patients receiving biological therapy do not have a higher risk of COVID-19
Sandro Ardizzone.
Leave a message here